Abeona Therapeutics Inc. Stock
Abeona Therapeutics Inc. Stock
The price for the Abeona Therapeutics Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.040 (-0.940%).
With 10 Buy predictions and not the single Sell prediction the community is currently very high on Abeona Therapeutics Inc..
With a target price of 17 € there is potential for a 304.76% increase which would mean more than doubling the current price of 4.2 € for Abeona Therapeutics Inc..
Our community identified positive and negative aspects for Abeona Therapeutics Inc. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Abeona Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Abeona Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Abeona Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc. | -0.940% | 1.942% | 1.942% | -2.778% | -9.871% | 69.218% | -86.987% |
| Heron Therapeutics Inc. | -0.410% | 10.879% | -0.581% | -54.196% | -30.925% | -70.630% | -94.480% |
| Evolus Inc | -0.550% | 3.399% | -16.590% | -59.326% | -33.578% | -51.733% | -63.061% |
| Sangamo Therapeutics Inc. | -0.810% | -2.426% | -34.637% | -67.260% | -37.907% | -85.570% | -97.764% |
Comments
Abeona Therapeutics (ABEO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics (ABEO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for ABEO provided by MarketBeat
Abeona Therapeutics (ABEO) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc..
Show more
Ratings data for ABEO provided by MarketBeat